🔎 Trials Near Me

Home › Schizophrenia › New York

Pag-aaral pangklinika para sa Schizophrenia sa New York

22 pag-aaral para sa Schizophrenia ang naghahanap ng mga kalahok sa mga site sa New York.

Mga Lungsod sa New York

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • Local Institution - 0061, Great Neck
Nagre-recruitPhase 3
Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07288567

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0061, Great Neck
  • Local Institution - 0171, Orangeburg
  • Local Institution - 0156, Staten Island
  • at 1 pa
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07424404

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • NYU Child Study Center, New York
  • Richmond Behavioral Associates, Staten Island
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06229210

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

  • Neurobehavioral Research Inc, Cedarhurst
  • Evolution Research Group, Staten Island
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07615426

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0037, Buffalo
  • Local Institution - 0004, Monsey
  • Local Institution - 0038, Rochester
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07379827

Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study

  • Zucker Hillside Hospital, New York
Nagre-recruit
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT05389787

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Cedarhurst
  • Clinical Site, New York
  • Clinical Site, Staten Island
  • at 1 pa
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07459647

iTBS to Enhance Social Cognition in People With Psychosis

  • Zucker Hillside Hospital, Glen Oaks
Nagre-recruit
Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT06118268

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Adams Clinical Harlem, New York
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07410507

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Radial - Manhattan, New York
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07101094

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

  • Neurocrine Clinical Site, Cedarhurst
  • Neurocrine Clinical Site, New York
  • Neurocrine Clinical Site, The Bronx
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227818

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Site, Cedarhurst
  • Neurocrine Clinical Site, New York
  • Neurocrine Clinical Site, New York
  • at 2 pa
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07114874

52-week Open Label Safety-Tolerability Study

  • Neuro-Behavioral Clinical Research, New York
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07369154

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

  • Alkermes Investigator Site, New York
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT05303064

Biomarkers to Enhance Early Schizophrenia Treatment

  • Feinstein Institute for Medical Research, Glen Oaks
Nagre-recruitPhase 4
Edad 18 hanggang 35 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06969755

MicroRNAs as Biomarkers in First Episode Schizophrenia

  • Zucker Hillside Hospital, Glen Oaks
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 15 hanggang 40 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07703670

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

  • Manhattan Psychiatric Center, New York
  • NewYork-Presbyterian/Weill Cornell Medical Center Westchester Division, White Plains
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT07434479

Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

  • NYU Langone Medical Center, New York
  • New York State Psychiatric Institute, New York
  • Manhattan Psychiatric Center, New York
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 4, 2026 · NCT05208190

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Staten Island
  • Neurocrine Clinical Site, The Bronx
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

  • Vanda Investigational Site, Staten Island
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT06961968

Study of ALTO-101 in Patients With Schizophrenia

  • Site 5108, New York
  • Site 5077, New York
  • Site 5126, White Plains
Nagre-recruitPhase 2
Edad 21 hanggang 55 · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT06502964

Visual Perception in Schizophrenia

  • University of Rochester, Rochester
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 12, 2025 · NCT06911931

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.